Biological Engineering
Biological engineering is a discipline that applies engineering principles to design solutions for challenges related to biological systems. This field is grounded in the biological sciences, similar to how chemical engineering, electrical engineering, and mechanical engineering are based on chemistry, electricity and magnetism, and classical mechanics, respectively.[2.1] The scope of biological engineering encompasses a wide range of applications, including the development of biomaterials, stem cell manufacturing, and the use of computational methods to model disease mechanisms.[5.1]
In 2023, significant advancements in stem cell technologies have emerged, particularly in the development of stem cell-based therapies. Notably, stem cells derived from cord blood have been shown to put the first mixed-race female patient with HIV into remission, marking a pivotal moment in the treatment of this disease.[19.1] Additionally, the largest cell therapy trial to date for chronic heart failure demonstrated the potential of mesenchymal precursor cells (MPCs) in addressing inflammation, while a milestone was achieved in treating Parkinson’s disease.[19.1] Furthermore, the UK Stem Cell Bank is exploring automated robotic technology for growing stem cells, which could enhance production efficiency despite existing challenges such as high manufacturing costs and contamination.[19.1] In parallel, engineered bacteria are being developed as live sensors, functioning as a new class of biosensors for the sensitive and noninvasive detection of diseases.[21.1] These bacterial whole-cell biosensors utilize advances in genetic engineering to create living machines capable of detecting disease biomarkers that may be undetectable by traditional methods.[21.1] The integration of biotechnology with artificial intelligence and data analytics is also transforming healthcare, facilitating the early detection and monitoring of diseases through advanced imaging techniques and liquid biopsies.[22.1] This synergy is fostering a new era of proactive and personalized healthcare, characterized by precision and innovation.[22.1]
Biological engineering is a multidisciplinary field that integrates life sciences with engineering principles to advance and apply fundamental concepts of biological systems across various levels, from molecular to ecosystem scales.[24.1] This integration is pivotal in developing innovative solutions in diverse application areas, including health, food, agriculture, and the environment.[24.1] The discipline is characterized by its science-based, application-independent nature, which allows for flexibility in pursuing various application areas.[24.1]
A core aspect of biological engineering is the application of molecular biology principles, which are essential for understanding and manipulating biological systems. Molecular biology, often considered the cornerstone of modern biological sciences, explores the fundamental processes governing all living organisms.[13.1] This field has led to the development of diagnostic methods and recombinant DNA technology, which are crucial for advancing biological engineering applications.[14.1] The central dogma of molecular biology, involving replication, transcription, and translation, forms the basis for these developments.[14.1]
Genetic engineering, a significant component of biological engineering, employs sophisticated techniques for precise DNA manipulation. These techniques are instrumental in advancing medical treatments and improving healthcare outcomes by enabling the development of therapies that address the root causes of genetic disorders.[16.1] Genetic engineering also explores methods to combat diseases by engineering human cells to resist viral infections or modifying the genetic material of pathogens.[16.1]
Furthermore, the integration of omics, Internet of Things (IoT), and artificial intelligence (AI) technologies facilitates the creation of medical digital twins. These digital twins allow for precise simulation of human physiological profiles, prediction of future health outcomes, and virtual individual clinical trials, thereby enabling personalized and preemptive medical interventions.[6.1] Although still in early development, digital medical twins hold promise for achieving precision and preemptive medicine, potentially improving healthcare outcomes and patient quality of life.[6.1]
The engineering perspective in precision medicine involves acquiring and validating population-wide data, such as -omics-based single-cell analysis and biomarker discovery, for application at the individual patient level.[7.1] This approach is supported by enabling technologies, including micro/nanofluidics for single circulating tumor cell analysis and nanotechnology for isolating extracellular vesicles and exosomes from liquid biopsies.[7.1] The introduction of phenotypic personalized medicine, which utilizes augmented AI to personalize combination therapy, has further enhanced the efficacy and safety of treatments based on specific patient phenotypes.[7.1]
The early developments in biological engineering were marked by significant breakthroughs and innovations that laid the foundation for modern biotechnology. In the late 1940s, Willem Kolff's research led to the advent of kidney dialysis, a pivotal advancement in medical treatment.[38.1] This period also saw the invention of the first artificial heart valve by Charles A. Hufnagel in 1952, followed by the first successful human heart surgery assisted by a heart-lung machine in 1953, performed by John H. Gibbon, Jr..[38.1] These innovations were complemented by the successful use of the first external cardiac pacemaker in 1958, marking a series of milestones in medical engineering.[38.1]
The discovery of the double helix structure of DNA in the 1950s was another landmark achievement that had a profound impact on the medical and biological sciences.[38.1] This discovery paved the way for the introduction of recombinant DNA technology in the 1970s, which marked the beginning of the modern era of bioengineering.[38.1] Recombinant DNA technology, which involves combining DNA from different species and inserting it into a host organism, was facilitated by breakthroughs such as the discovery of restriction enzymes and reverse transcriptase in the 1960s and 1970s.[62.1] These advancements allowed scientists to generate recombinant DNA molecules, revolutionizing genetic engineering and opening up new possibilities for manipulating and modifying genes.[63.1]
The development of recombinant DNA technology was a pivotal moment in biotechnology, enabling the manipulation and transfer of genes between different organisms.[63.1] This breakthrough led to a wide range of applications, including the production of genetically modified crops and the development of new medical treatments.[63.1] The discovery and development of CRISPR-Cas9 technology further revolutionized genetic engineering, allowing for unprecedented precision and ease in gene manipulation.[36.1] These early developments in biological engineering not only transformed the field but also set the stage for future innovations and applications across various industries.
Recent advancements in cell biology have been significantly influenced by the development of genome editing technologies, particularly CRISPR-Cas9. This technology has revolutionized the life sciences and human medicine by providing unprecedented opportunities to dissect complex biological processes and address the underlying causes of numerous genetic diseases. The remarkable efficiency and programmability of CRISPR-based technologies have positioned them at the forefront of genetic research and therapeutic applications.[84.1]
The precision of CRISPR/Cas9 technology allows for selective modification of DNA sequences at specific genomic locations, surpassing the capabilities of older genome editing technologies such as TALEN and ZFN. This precision has facilitated significant research efforts, particularly in the engineering of CAR-T cells, which are modified using CRISPR-linked systems to induce heritable changes. These advancements hold promise for precision and personalized medicine, as well as cancer treatment, by enabling more targeted and effective therapeutic interventions.[85.1]
In addition to genome editing, recent studies have uncovered hierarchical arrangements within bone marrow niches that govern stem cell regeneration and immune privilege. These niches enforce a hierarchy among hematopoietic stem cells (HSCs), influencing their regenerative capacities and immune properties. The presence of niche-specific regulatory T cells and immunosuppressive molecules contributes to immune tolerance, offering novel therapeutic strategies for enhancing transplantation outcomes and regenerative medicine.[93.1] The identification of NOhi HSCs as highly immune-privileged, primitive stem cells, governed by unique vascular niches, underscores the critical role of these microenvironments in maintaining stem-cell homeostasis and immune tolerance.[94.1]
Artificial Intelligence (AI) has significantly impacted the field of biological engineering, particularly in the development of medical devices and personalized medicine. AI has revolutionized bioinformatics by introducing machine learning (ML) and deep learning (DL) techniques capable of efficiently processing vast biological datasets. This advancement is crucial for scientists, engineers, and medical professionals as it enhances their ability to analyze complex biological data, thereby facilitating the development of innovative medical devices.[78.1]
One of the most notable applications of AI in medical devices is its role in personalized medicine. AI is now playing a key role in developing personalized treatment plans, where treatments are customized for each patient. By analyzing past data, AI can predict which treatments are likely to be effective, thereby improving treatment outcomes. This involves the use of predictive models that forecast how a patient will respond to different treatments, helping doctors choose the best option.[89.1] Furthermore, AI-driven tools provide unprecedented insights into genomic data, identifying patterns and predicting outcomes, which are essential for advancing personalized medicine. This integration of AI into precision medicine is revolutionizing healthcare by enabling highly personalized, data-driven approaches to diagnosis, treatment, and prevention.[90.1]
Moreover, AI is transforming the way scientific discoveries are made by improving experiments, revealing hidden patterns in massive datasets, automating tasks, and making it easier to model complex systems. This transformation is evident in the development of algorithms for tackling complex biological challenges such as molecular structure deciphering, DNA analysis, and phenotype understanding. By fostering collaboration between computational and biological scientists, AI is accelerating the next generation of discoveries in biological engineering.[79.1]
Bioengineering plays a pivotal role in the medical and healthcare sectors by applying engineering principles to solve biological problems and develop innovative healthcare technologies. This multidisciplinary field combines biology, chemistry, genetics, and engineering to create solutions that improve human health and well-being.[112.1] One of the significant contributions of bioengineering is in regenerative medicine, where it aids in the development of human organs and tissues, offering potential solutions for organ failure and tissue damage.[110.1]
In the realm of diagnostics and treatment, bioengineering has facilitated the creation of more effective diagnostic tools and bioengineered treatments. These advancements are supported by breakthroughs such as the mapping of the human genome and the decreasing cost of DNA sequencing, which have propelled innovations in cell, gene, and RNA therapies aimed at treating or preventing diseases.[111.1] Additionally, bioengineering has contributed to the development of antiaging treatments, reproductive medicine innovations, and improvements in drug development and delivery systems.[111.1]
The integration of machine learning (ML) and artificial intelligence (AI) in bioinformatics is transforming drug development and personalized medicine. ML techniques enhance decision-making in pharmaceutical data analysis, aiding in various stages of drug discovery, including target validation and the identification of prognostic biomarkers.[116.1] AI algorithms have enabled advancements in target discovery, compound screening, and molecular design, among other areas, by mining correlations between multi-omics data and patient health information.[115.1] This integration is paving the way for personalized medicine, which tailors treatments based on an individual's genetic makeup, moving away from the traditional "one size fits all" approach.[117.1]
Furthermore, bioinformatics tools, powered by AI and ML, are providing valuable insights into disease mechanisms and patient-specific responses to treatments, facilitating the transition towards personalized healthcare.[117.1] These tools are instrumental in predicting disease risk and understanding drug efficacy, thereby improving clinical success rates and enhancing patient outcomes.[118.1]
Ethical considerations in biological engineering are multifaceted and arise from the need to balance innovation with societal values and environmental integrity. Historically, research ethics have evolved from concerns about the treatment and use of natural entities, such as humans, animals, and genetic materials, which are believed to possess moral status or considerability.[156.1] In the context of biological engineering, ethical guidelines are essential to ensure that advancements benefit society while minimizing potential harms. The Engineering Biology Research Consortium (EBRC) has outlined six core ethical principles: using engineering biology for global benefit, weighing research benefits against potential harms, incorporating justice, sharing research, protecting individual and researcher freedoms, and supporting open communication among stakeholders.[157.1]
The unique challenges posed by biological engineering necessitate a distinct code of ethics, as the moral questions faced by bioengineers are not merely subsets of other fields. For instance, issues such as live vertebrate testing and the largely unregulated nature of genetic engineering in the U.S. require careful ethical consideration to ensure respect and care for the human species.[158.1] Companies involved in genetic engineering must balance innovation with accountability, ensuring that their practices do not harm individuals, communities, or the environment.[159.1] Moreover, genetic technologies have the potential to exacerbate social disparities, raising ethical dilemmas related to fair access to benefits, ownership, and the commercialization of genetic information.[160.1]
Transparency plays a crucial role in building trust around innovations in biological engineering. The scientific community is encouraged to endorse and improve existing principles and practices to promote transparency, such as data sharing and transparent reporting, which reinforce scientific norms and sustain trust.[174.1] Regulatory frameworks that emphasize transparency and accountability are vital for reinstating trustworthiness in biomedical research. Institutions must create environments that promote responsible conduct by adhering to standards of excellence, trustworthiness, and lawfulness.[175.1]
Public engagement is another critical aspect of addressing ethical considerations in biological engineering. The field of synthetic biology, for example, has highlighted the importance of public perception and participation. Initiatives like DIYbio and iGEM competitions have fostered public engagement and contributed to the governance and responsible innovation in synthetic biology.[176.1] Engaging the public and stakeholders in discussions about the ethical implications of biological engineering is essential for ensuring that these technologies are developed and applied in ways that align with societal values and ethical standards.
Biological engineering is poised to address numerous global challenges, particularly in the realms of medicine, agriculture, and environmental sustainability. The U.S. National Academy of Engineering has identified these areas as critical for future research and development, emphasizing the importance of sustainability, health, and overall human welfare.[149.1] The American Institute for Medical and Biological Engineering (AIMBE) has further outlined six major societal challenges that biological engineers are expected to tackle in the coming decades. These include engineering safe and sustainable water and food supplies, personalized healthcare, solutions to injury and chronic diseases, global health improvements through infectious disease prevention, sustainable bioenergy production, and the advancement of the 21st-century economy.[150.1]
In the field of bioenergy, recent advancements in algal fuel research highlight the potential of genetic engineering, such as CRISPR-modified strains, to increase lipid yields for biofuel production. These innovations, along with novel bioreactor designs, are enhancing scalability and energy efficiency, while integration with waste-to-energy systems offers resource recovery and cost savings.[152.1] Despite the promise of algae as a sustainable fuel source, challenges remain in achieving economic viability due to low productivities. High-throughput strain engineering, omics-informed genome-scale modeling, and microbiome engineering are pivotal technologies that could enable the realization of algal biofuels.[153.1]
Moreover, biological engineering is expected to play a crucial role in mitigating the impacts of climate change. By integrating landscape-management solutions with engineering principles, biological engineers can contribute to Nature-based Climate Solutions (NbCS) that harness ecosystems' photosynthetic power to store carbon and reduce greenhouse gas emissions. This approach involves strategies such as peatland restoration, forest agriculture, and improved nutrient management, which are essential for developing a productive and resilient "climate-smart agriculture" system.[162.1] As these fields evolve, the international community must establish guidelines to ensure the responsible use of emerging technologies, balancing their potential benefits with the risks they pose.[151.1]
Biological engineering offers a plethora of academic and research opportunities, particularly in areas where cutting-edge technologies intersect with biological sciences. One of the most promising fields is personalized medicine, which leverages advancements in genetics and artificial intelligence (AI) to tailor medical treatments to individual patients. This approach allows healthcare professionals to gain a comprehensive understanding of a patient's unique biological makeup, thereby informing more effective treatment strategies.[229.1]
AI has become a pivotal force in biomedical research, significantly accelerating the drug discovery process. By 2025, machine learning algorithms are expected to reduce the time required to identify viable drug candidates from years to mere months. AI's capability to analyze complex datasets from genomics, proteomics, and metabolomics is uncovering new insights into disease mechanisms, which is crucial for the development of novel therapies, including mRNA vaccines and CRISPR-Cas9-based treatments.[232.1]
CRISPR-Cas9 technology, initially a precise gene-editing tool, has evolved into a versatile platform for programmable biological systems. Its applications have expanded beyond research laboratories into mainstream clinical use, where it is employed to correct genetic defects and treat inherited diseases. This technology is also being used to reprogram microorganisms for sustainable production of biofuels, biodegradable plastics, and high-value chemicals, thereby revolutionizing biomanufacturing processes.[233.1]
Synthetic biology is another transformative area within biological engineering, facilitating the creation of new materials and the development of novel therapeutics. The integration of synthetic biology into biomanufacturing has accelerated the advancement of cell-based therapies and personalized medicines, offering groundbreaking treatments for previously untreatable conditions.[233.1]
Furthermore, research in biomaterials is advancing tissue engineering, with innovations such as biocompatible scaffolds and hydrogels that support cell growth and enhance therapy delivery. This field is crucial for developing regenerative approaches to repair damaged tissues and manage chronic conditions.[230.1] The explosion of investment in single-cell analysis technologies is also noteworthy, as these techniques are pivotal for early disease detection, prenatal screening, and biologic drug development.[231.1]
Bioengineers employed in industry work in diverse settings, including medical device, biotech, and pharmaceutical companies, as well as medical equipment and supply manufacturers. In these roles, they may design instruments, devices, and software, and bring together knowledge from various technical sources to develop new procedures. They also conduct research needed to solve clinical problems and teach health professionals how to use new medical technologies.[188.1] Bioengineers are also employed in clinical environments, working in hospitals, clinics, and other healthcare settings, where they apply their expertise to improve patient care and healthcare delivery.[188.1]
In the industry, bioengineers are involved in developing pharmaceuticals, cell and gene therapies, and creating medical equipment to enhance the health of humans, plants, and animals. Their work spans from hospitals and clinics to the labs and conference rooms of leading manufacturing companies across various industries.[190.1] Bioengineers play a crucial role in advancing healthcare innovations, such as biocompatible implants and advanced stem cell applications, by blending life sciences with engineering concepts.[189.1] This interdisciplinary approach allows them to address complex healthcare challenges and contribute significantly to the development of life-saving medical technologies.[194.1]
19
europeanpharmaceuticalreview.com
152
onlinelibrary.wiley.com